Advertisement
U.S. markets closed

Acotec Scientific Holdings Limited (6669.HK)

HKSE - HKSE Delayed Price. Currency in HKD
7.840+0.120 (+1.55%)
At close: 03:57PM HKT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.720
Open7.600
Bid7.600 x N/A
Ask7.960 x N/A
Day's Range7.530 - 8.660
52 Week Range7.250 - 17.000
Volume287,000
Avg. Volume223,465
Market Cap2.457B
Beta (5Y Monthly)0.11
PE Ratio (TTM)156.80
EPS (TTM)0.050
Earnings DateMar 25, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.07
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 6669.HK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Reuters

      UPDATE 2-Boston Scientific to buy chronic back pain therapy maker Relievant

      Medical devices maker Boston Scientific said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million, gaining access to an FDA-cleared therapy for chronic pain. The Massachusetts-based company is also obliged to pay Relievant additional undisclosed payments based on sales performance over the next three years. The deal is the latest in a string of acquisitions by Boston Scientific, which makes pacemakers, stents and catheters, to boost its portfolio of devices.